Episode Details
Back to Episodes
Episode 321 ASCO24: CHAARTED-2 in prostate cancer - is the sequel as good as the original?
Season 3
Episode 321
Published 2 years, 4 months ago
Description
Christos Kyriakopoulos describes the outcome of this study, where cabazitaxel with abiraterone as combined with abiraterone alone in docetaxel refractory CRPC.